Several established cancer-related pathways and hallmarks, including the “NF-kappa B signaling pathway”, “EMT”, “hypoxia”, “KRAS signaling”, and “p53 pathway”, were enriched in the high-risk group, indicating the internal regulatory mechanisms of the components of the lncRNA signature in the progression and metastasis of GC. The gene discussed is KRAS; the disease is cancer.